Mediolanum International Funds Ltd Makes New Investment in Amrize Ltd $AMRZ

Mediolanum International Funds Ltd purchased a new stake in Amrize Ltd (NYSE:AMRZ) during the 1st quarter, Holdings Channel reports. The firm purchased 37,857 shares of the company’s stock, valued at approximately $2,037,000.

A number of other hedge funds also recently made changes to their positions in the business. MCF Advisors LLC acquired a new position in shares of Amrize during the fourth quarter worth approximately $27,000. Basepoint Wealth LLC acquired a new stake in Amrize in the 4th quarter valued at approximately $33,000. Laurel Wealth Advisors LLC acquired a new stake in Amrize in the 4th quarter valued at approximately $34,000. US Bancorp DE bought a new stake in Amrize during the 3rd quarter valued at $38,000. Finally, Itau Unibanco Holding S.A. raised its stake in Amrize by 150.0% during the 4th quarter. Itau Unibanco Holding S.A. now owns 750 shares of the company’s stock valued at $41,000 after acquiring an additional 450 shares in the last quarter.

Amrize Stock Performance

Shares of NYSE AMRZ opened at $48.65 on Wednesday. The stock has a fifty day moving average price of $52.16 and a two-hundred day moving average price of $55.23. The company has a debt-to-equity ratio of 0.38, a quick ratio of 0.89 and a current ratio of 1.40. The firm has a market cap of $26.91 billion and a P/E ratio of 23.28. Amrize Ltd has a 1 year low of $44.12 and a 1 year high of $65.94.

Amrize (NYSE:AMRZ) last issued its quarterly earnings results on Wednesday, April 29th. The company reported ($0.16) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.14) by ($0.02). Amrize had a net margin of 9.70% and a return on equity of 9.84%. The firm had revenue of $2.18 billion for the quarter. The business’s revenue was up 4.7% compared to the same quarter last year. Research analysts forecast that Amrize Ltd will post 2.74 EPS for the current fiscal year.

Amrize Cuts Dividend

The company also recently announced a dividend, which was paid on Wednesday, May 20th. Investors of record on Tuesday, May 12th were issued a dividend of $0.11 per share. The ex-dividend date of this dividend was Tuesday, May 12th. Amrize’s payout ratio is presently 21.05%.

Insider Transactions at Amrize

In other Amrize news, CEO Jan Philipp Jenisch purchased 21,417 shares of the business’s stock in a transaction on Friday, May 15th. The stock was bought at an average cost of $49.67 per share, with a total value of $1,063,782.39. Following the acquisition, the chief executive officer owned 1,724,999 shares of the company’s stock, valued at $85,680,700.33. The trade was a 1.26% increase in their ownership of the stock. The acquisition was disclosed in a legal filing with the SEC, which is available through this hyperlink. Also, insider Nollaig Forrest acquired 2,000 shares of Amrize stock in a transaction dated Friday, May 22nd. The shares were acquired at an average price of $50.25 per share, with a total value of $100,500.00. Following the transaction, the insider owned 20,139 shares in the company, valued at approximately $1,011,984.75. This represents a 11.03% increase in their position. The disclosure for this purchase is available in the SEC filing. Insiders bought 54,920 shares of company stock valued at $2,717,429 in the last three months. 0.54% of the stock is currently owned by insiders.

Analyst Upgrades and Downgrades

A number of research analysts have issued reports on AMRZ shares. Vertical Research upgraded Amrize from a “hold” rating to a “buy” rating and set a $70.00 price target for the company in a research report on Friday, May 1st. Sanford C. Bernstein restated an “outperform” rating on shares of Amrize in a research note on Monday, June 22nd. Royal Bank Of Canada decreased their target price on shares of Amrize from $61.00 to $60.00 and set a “sector perform” rating for the company in a research report on Friday, May 1st. Deutsche Bank Aktiengesellschaft reissued a “buy” rating on shares of Amrize in a research note on Friday, June 26th. Finally, Stephens restated an “overweight” rating and set a $65.00 price target on shares of Amrize in a research report on Monday, May 18th. One research analyst has rated the stock with a Strong Buy rating, nine have issued a Buy rating and seven have assigned a Hold rating to the company. According to MarketBeat, Amrize currently has a consensus rating of “Moderate Buy” and a consensus target price of $62.79.

Amrize Profile

Amrize AG focuses on building materials business in North America. The company was incorporated in 2023 and is based in Zug, Switzerland. Amrize AG operates independently of Holcim AG as of June 23, 2025.